1. Home
  2. LQDT vs LXRX Comparison

LQDT vs LXRX Comparison

Compare LQDT & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LQDT
  • LXRX
  • Stock Information
  • Founded
  • LQDT 1999
  • LXRX 1995
  • Country
  • LQDT United States
  • LXRX United States
  • Employees
  • LQDT N/A
  • LXRX N/A
  • Industry
  • LQDT Catalog/Specialty Distribution
  • LXRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LQDT Consumer Discretionary
  • LXRX Health Care
  • Exchange
  • LQDT Nasdaq
  • LXRX Nasdaq
  • Market Cap
  • LQDT 678.4M
  • LXRX 650.7M
  • IPO Year
  • LQDT 2006
  • LXRX 2000
  • Fundamental
  • Price
  • LQDT $24.90
  • LXRX $0.98
  • Analyst Decision
  • LQDT Buy
  • LXRX Buy
  • Analyst Count
  • LQDT 1
  • LXRX 2
  • Target Price
  • LQDT $27.00
  • LXRX $6.00
  • AVG Volume (30 Days)
  • LQDT 115.2K
  • LXRX 4.3M
  • Earning Date
  • LQDT 12-12-2024
  • LXRX 11-12-2024
  • Dividend Yield
  • LQDT N/A
  • LXRX N/A
  • EPS Growth
  • LQDT N/A
  • LXRX N/A
  • EPS
  • LQDT 0.62
  • LXRX N/A
  • Revenue
  • LQDT $336,348,000.00
  • LXRX $5,229,000.00
  • Revenue This Year
  • LQDT $13.35
  • LXRX $1,212.46
  • Revenue Next Year
  • LQDT $6.94
  • LXRX $219.10
  • P/E Ratio
  • LQDT $40.13
  • LXRX N/A
  • Revenue Growth
  • LQDT 8.60
  • LXRX 886.60
  • 52 Week Low
  • LQDT $13.99
  • LXRX $0.97
  • 52 Week High
  • LQDT $25.79
  • LXRX $3.73
  • Technical
  • Relative Strength Index (RSI)
  • LQDT 70.07
  • LXRX 25.78
  • Support Level
  • LQDT $21.34
  • LXRX $1.01
  • Resistance Level
  • LQDT $25.79
  • LXRX $1.35
  • Average True Range (ATR)
  • LQDT 0.51
  • LXRX 0.12
  • MACD
  • LQDT 0.30
  • LXRX -0.06
  • Stochastic Oscillator
  • LQDT 80.00
  • LXRX 0.43

About LQDT Liquidity Services Inc.

Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Capital Assets Group (CAG), Retail Supply Chain Group (RSCG), and Machinio. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

Share on Social Networks: